Market Research Logo

Interprotein Corporation - Product Pipeline Review - 2016

Interprotein Corporation - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Interprotein Corporation - Product Pipeline Review - 2016’, provides an overview of the Interprotein Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Interprotein Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Interprotein Corporation
The report provides overview of Interprotein Corporation including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Interprotein Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Interprotein Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Interprotein Corporation’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Interprotein Corporation
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Interprotein Corporation’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Interprotein Corporation Snapshot
Interprotein Corporation Overview
Key Information
Key Facts
Interprotein Corporation - Research and Development Overview
Key Therapeutic Areas
Interprotein Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Interprotein Corporation - Pipeline Products Glance
Interprotein Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Interprotein Corporation - Drug Profiles
IPC-003
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit VEGF for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit gp130 for Inflammation and Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit IgE for Allergies
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit RUNX1 for Acute Myeloid Leukemia
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit gp130 for Inflammation and Oncology
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides to Antagonize KIR for Oncology
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides to Antagonize NKG2A for Oncology
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides to Inhibit TIM-3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Interprotein Corporation - Pipeline Analysis
Interprotein Corporation - Pipeline Products by Target
Interprotein Corporation - Pipeline Products by Route of Administration
Interprotein Corporation - Pipeline Products by Molecule Type
Interprotein Corporation - Pipeline Products by Mechanism of Action
Interprotein Corporation - Recent Pipeline Updates
Interprotein Corporation - Dormant Projects
Interprotein Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Interprotein Corporation, Key Information
Interprotein Corporation, Key Facts
Interprotein Corporation - Pipeline by Indication, 2016
Interprotein Corporation - Pipeline by Stage of Development, 2016
Interprotein Corporation - Monotherapy Products in Pipeline, 2016
Interprotein Corporation - Partnered Products in Pipeline, 2016
Interprotein Corporation - Partnered Products/ Combination Treatment Modalities, 2016
Interprotein Corporation - Out-Licensed Products in Pipeline, 2016
Interprotein Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2016
Interprotein Corporation - Preclinical, 2016
Interprotein Corporation - Discovery, 2016
Interprotein Corporation - Pipeline by Target, 2016
Interprotein Corporation - Pipeline by Route of Administration, 2016
Interprotein Corporation - Pipeline by Molecule Type, 2016
Interprotein Corporation - Pipeline Products by Mechanism of Action, 2016
Interprotein Corporation - Recent Pipeline Updates, 2016
Interprotein Corporation - Dormant Developmental Projects,2016
Interprotein Corporation, Other Locations
List of Figures
Interprotein Corporation - Pipeline by Indication, 2016
Interprotein Corporation - Pipeline by Stage of Development, 2016
Interprotein Corporation - Monotherapy Products in Pipeline, 2016
Interprotein Corporation - Pipeline by Target, 2016
Interprotein Corporation - Pipeline by Molecule Type, 2016
Interprotein Corporation - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report